Mohamed Amine Fouad , Nesrine Ben Salah , Mouna Korbi , Yousra Soua , Asma Mabrouk , Hichem Bel Hadj Ali , Jameleddine Zili
{"title":"Cutaneous sarcoidosis beyond the skin: Exploring endocrine comorbidities","authors":"Mohamed Amine Fouad , Nesrine Ben Salah , Mouna Korbi , Yousra Soua , Asma Mabrouk , Hichem Bel Hadj Ali , Jameleddine Zili","doi":"10.1016/j.ando.2025.101747","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Sarcoidosis is a chronic systemic inflammatory disease characterized by tissue infiltration of non-caseating granulomas. This study aims to identify endocrine disorders associated with sarcoidosis and determine their frequency in cutaneous sarcoidosis.</div></div><div><h3>Materials and methods</h3><div>A retrospective study was conducted between 2017 and 2025, including all patients followed for cutaneous sarcoidosis. The study included 11 patients, all female, with a mean age of 65.4 years (range: 57–73 years).</div></div><div><h3>Results and discussion</h3><div>Five cases presented with associated endocrinopathies: diabetes mellitus in 3 cases (2 with type 2 diabetes and 1 with type 1 diabetes), hypothyroidism in 1 case, and dyslipidemia in 1 case. The localization was cutaneous in all cases, pulmonary in 4 cases, hepatic in 1 case, and ophthalmological in 1 case. Treatment involved oral corticosteroids in 10 patients, while 1 patient received hydroxychloroquine due to isolated cutaneous involvement. The association between cutaneous sarcoidosis and endocrinopathies is rarely reported in the literature. Potential mechanisms include a direct effect on endocrine glands, shared pathophysiological pathways, or the effects of treatment, particularly corticosteroids.</div></div><div><h3>Conclusion</h3><div>This study highlights the importance of screening for endocrine comorbidities in patients with cutaneous sarcoidosis to optimize management. In conclusion, although endocrinopathies are uncommon, they can accompany cutaneous sarcoidosis. Their identification requires clinical vigilance and a multidisciplinary approach to improve overall patient care.</div></div>","PeriodicalId":7917,"journal":{"name":"Annales d'endocrinologie","volume":"86 3","pages":"Article 101747"},"PeriodicalIF":2.9000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales d'endocrinologie","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0003426625000666","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Sarcoidosis is a chronic systemic inflammatory disease characterized by tissue infiltration of non-caseating granulomas. This study aims to identify endocrine disorders associated with sarcoidosis and determine their frequency in cutaneous sarcoidosis.
Materials and methods
A retrospective study was conducted between 2017 and 2025, including all patients followed for cutaneous sarcoidosis. The study included 11 patients, all female, with a mean age of 65.4 years (range: 57–73 years).
Results and discussion
Five cases presented with associated endocrinopathies: diabetes mellitus in 3 cases (2 with type 2 diabetes and 1 with type 1 diabetes), hypothyroidism in 1 case, and dyslipidemia in 1 case. The localization was cutaneous in all cases, pulmonary in 4 cases, hepatic in 1 case, and ophthalmological in 1 case. Treatment involved oral corticosteroids in 10 patients, while 1 patient received hydroxychloroquine due to isolated cutaneous involvement. The association between cutaneous sarcoidosis and endocrinopathies is rarely reported in the literature. Potential mechanisms include a direct effect on endocrine glands, shared pathophysiological pathways, or the effects of treatment, particularly corticosteroids.
Conclusion
This study highlights the importance of screening for endocrine comorbidities in patients with cutaneous sarcoidosis to optimize management. In conclusion, although endocrinopathies are uncommon, they can accompany cutaneous sarcoidosis. Their identification requires clinical vigilance and a multidisciplinary approach to improve overall patient care.
期刊介绍:
The Annales d''Endocrinologie, mouthpiece of the French Society of Endocrinology (SFE), publishes reviews, articles and case reports coming from clinical, therapeutic and fundamental research in endocrinology and metabolic diseases. Every year, it carries a position paper by a work-group of French-language endocrinologists, on an endocrine pathology chosen by the Society''s Scientific Committee. The journal is also the organ of the Society''s annual Congress, publishing a summary of the symposia, presentations and posters. "Les Must de l''Endocrinologie" is a special booklet brought out for the Congress, with summary articles that are always very well received. And finally, we publish the high-level instructional courses delivered during the Henri-Pierre Klotz International Endocrinology Days. The Annales is a window on the world, keeping alert clinicians up to date on what is going on in diagnosis and treatment in all the areas of our specialty.